Mamadou Diallo, PharmD, has worked in biopharmaceutical sciences, drug development, and manufacturing improvement processes for over two decades. Dr. Diallo is also experienced with global health authorities’ CMC perspectives/compliance requirements, risk posture, and risk mitigation. His areas of focus are large molecules (e.g., biologics), small molecules, and combination products. Within Cardinal Health Regulatory Sciences, Dr. Diallo manages cross-functional teams of regulatory scientists.